Mode
Text Size
Log in / Sign up

Pregnancy induced hypertension

Part of Hypertension

Subtypes of Pregnancy induced hypertension

Preeclampsia 25 Pre-eclampsia 8 Eclampsia 1 HELLP syndrome 0

38 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Pregnancy induced hypertension

10 trials tracked for Pregnancy induced hypertension: 4 in phase 3 or 4 and 1 with published results. The most-cited published study has 8 citations.

10Trials tracked
4Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 2 Phase 3 2 Phase 2 1 Phase 1 1 Other / NA 4
  1. Phase 3 Furosemide vs. Placebo for Severe Antepartum Hypertension Completed · 8 cited
  2. Phase 4 The Effect of Ibuprofen on Post-partum Blood Pressure in Women With Hypertensive Disorders of Pregnancy Completed
  3. Phase 4 Optimal Blood Pressure Treatment Thresholds Postpartum Completed
  4. Phase 3 Lasix for the Prevention of De Novo Postpartum Hypertension Completed
  5. Phase 2 Furosemide for Accelerated Recovery of Blood Pressure Postpartum Completed
  6. Phase 1 Phase I Study of Nicotinamide for Early Onset Preeclampsia Completed
Show 4 more trials
  1. N/A Expanding the Family Check-Up in Early Childhood to Promote Cardiovascular Health of Mothers and Young Children Completed
  2. N/A Hypertension In Postpartum Preeclampsia Study Completed
  3. N/A Comprehensive Postpartum Management for Women With Hypertensive Disorders of Pregnancy Completed
  4. N/A Postpartum Hypertension: Remote Patient Monitoring Completed

Showing the 10 most-cited and recently-updated of 10 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found Updated — new results For clinicians

Pregnancy induced hypertension: what the trials found

Furosemide was evaluated for blood pressure management; results showed varying outcomes in systolic and diastolic blood pressures at 2 hours post-administration, with recorded values of 139/84 and 154/87 respectively 4. Additionally, the percentage of recorded blood pressures that were elevated was reported across multiple instances 5.

In a study comparing ibuprofen and acetaminophen for pain control over a 24-hour period, patient satisfaction with pain control was significantly higher in the acetaminophen group (p=0.02) 3. Pain scores measured by nursing assessment did not show significant differences between the two interventions (p=0.76) 3.

Recent results — preliminary, needs further review

  • A study on blood pressure control targets showed systolic blood pressures at 4-6 weeks post-intervention ranging from 121.1 to 132 8.
  • The 'Family Check Up Heart' intervention was evaluated for postpartum weight outcomes, showing mean weights of 200.2 and 202.1 at 6 months postpartum 2.

For the clinician treating this condition

  • Acetaminophen was associated with significantly higher patient satisfaction regarding pain control compared to ibuprofen over a 24-hour period 3.
  • Furosemide is utilized in the management of blood pressure, though specific efficacy in reducing elevated blood pressure percentages varies across clinical settings [4, 5].

AI synthesis of 5 cited trials, updated Jun 29, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Hypertension

Related studies from across the Hypertension family.

Nocturnal hypertension affects 42.5% of population samples, isolated nocturnal hypertension 17.3%
Cardiology Meta-analysis
Nocturnal hypertension affects 42.5% of population samples, isolated nocturnal hypertension 17.3% High blood pressure during sleep is common in many people
This meta-analysis estimates the prevalence of nocturnal hypertension and isolated nocturnal hypertension in population-based and community …
Nearly half of people with high blood pressure experience it specifically at night, a finding that helps doctors plan better screening tools…
Study-defined hypertension is not a statistically significant predictor of recurrence in intracranial aneurysms
Neurology Meta-analysis
Study-defined hypertension is not a statistically significant predictor of recurrence in intracranial aneurysms High blood pressure may not predict aneurysm recurrence after treatment
This systematic review and meta-analysis of 2,442 observations from 8 studies found no statistically significant association between study-d…
New data suggests that a history of high blood pressure does not clearly predict if an aneurysm will return after surgery.
Short-chain fatty acids and intestinal macrophages modulate metabolism in metabolic syndrome and obesity
Nutrition & Obesity Medicine Sys. Review
Short-chain fatty acids and intestinal macrophages modulate metabolism in metabolic syndrome and obesity Short Chain Fatty Acids May Help Manage Metabolic Syndrome
This narrative review explores how short-chain fatty acids (SCFAs) like butyrate, acetate, and propionate influence intestinal macrophage im…
Short-chain fatty acids like butyrate may influence how the body handles inflammation and metabolism in people with obesity and insulin resi…
Gut microbiome dysbiosis may contribute to cognitive decline through neuroinflammation and hypertension-mediated cerebrovascular injury
Neurology Sys. Review
Gut microbiome dysbiosis may contribute to cognitive decline through neuroinflammation and hypertension-mediated cerebrovascular injury Gut health and blood pressure may impact brain health
This narrative review explores the gut-brain-vascular axis, proposing that gut microbiome dysbiosis contributes to cognitive decline via neu…
New research explores how an unbalanced gut and high blood pressure might work together to cause brain aging and cognitive decline.
RAAS inhibitors modulate inflammatory responses and oxidative stress across multiple chronic conditions
Drug Pipeline Sys. Review
RAAS inhibitors modulate inflammatory responses and oxidative stress across multiple chronic conditions RAAS Inhibitors May Protect Organs Beyond Lowering Blood Pressure
This systematic review synthesizes the roles of ACEI, ARB, DRI, ARNI, and MRA in modulating inflammatory responses and oxidative stress. The…
New research suggests certain blood pressure medications may protect the heart, kidneys, and lungs by reducing inflammation and oxidative st…
Aerobic Training Lowers Blood Pressure in Hypertension Across 26 Studies
Cardiology Meta-analysis
Aerobic Training Lowers Blood Pressure in Hypertension Across 26 Studies Aerobic training shows significant blood pressure drops for adults
This meta-analysis of 26 studies (1,576 adults with hypertension) found that aerobic training produced statistically significant and clinica…
Aerobic exercise provides meaningful reductions in both systolic and diastolic blood pressure for adults living with hypertension.
KLF1 variants identified in neonate with severe hemolytic anemia and pulmonary hypertension
Pediatrics Sys. Review
KLF1 variants identified in neonate with severe hemolytic anemia and pulmonary hypertension Genetic testing helps identify a rare cause of severe anemia
This case report and literature review describes a neonate with unexplained Coombs/DAT-negative severe hemolytic anemia, pulmonary hypertens…
A rare genetic variant in the KLF1 gene can cause severe anemia and lung issues in newborns, making early testing vital for accurate diagnos…
AI prescreening tool identifies primary aldosteronism with AUROC 0.709 in hypertension
Diabetes & Endocrinology RCT
AI prescreening tool identifies primary aldosteronism with AUROC 0.709 in hypertension AI tool helps identify patients with high blood pressure condition
In a retrospective cohort of 22,264 adults with hypertension or PA testing, an AI prescreening tool using EHR data achieved an AUROC of 0.70…
A new AI tool uses electronic health records to help doctors find patients who need testing for a specific heart condition.
Aquatic Exercise Therapy for Blood Pressure Management in Elderly Patients with Hypertension
Cardiology Meta-analysis
Aquatic Exercise Therapy for Blood Pressure Management in Elderly Patients with Hypertension Pool workouts may lower blood pressure in older adults
Aquatic exercise therapy significantly lowers systolic and diastolic blood pressure in elderly patients, offering a viable non-pharmacologic…
A new analysis finds aquatic exercise may cut systolic blood pressure by about 11 points in older adults with hypertension.
Mineralocorticoid receptor antagonists exert cardioprotective effects by restoring coronary microvascular function
Cardiology Sys. Review
Mineralocorticoid receptor antagonists exert cardioprotective effects by restoring coronary microvascular function Mineralocorticoid Receptor Antagonists May Improve Heart Function in Heart Failure
This mini-review examines the mechanisms of mineralocorticoid receptor antagonists in patients with heart failure, hypertension, and chronic…
New research highlights how mineralocorticoid receptor antagonists may protect the heart by improving blood flow in small vessels for patien…
One anastomosis gastric bypass provides durable weight loss and metabolic improvements over 15 years
Nutrition & Obesity Medicine Meta-analysis
One anastomosis gastric bypass provides durable weight loss and metabolic improvements over 15 years Gastric Bypass Shows Durable Weight Loss and Health Improvements
This meta-analysis of 1729 patients evaluates the long-term outcomes of one anastomosis gastric bypass (OAGB). The analysis indicates durabl…
Gastric bypass surgery can lead to lasting weight loss and improved conditions like diabetes and high blood pressure over 15 years.
Selective aldosterone synthase inhibitors reduce systolic blood pressure by 7.9 mmHg in patients with CKD
Nephrology Meta-analysis
Selective aldosterone synthase inhibitors reduce systolic blood pressure by 7.9 mmHg in patients with CKD Aldosterone Synthase Inhibitors May Lower Blood Pressure in CKD Patients
This meta-analysis of 1148 patients with CKD and uncontrolled hypertension found that selective aldosterone synthase inhibitors (ASIs) reduc…
New research suggests that aldosterone synthase inhibitors could help manage high blood pressure and kidney damage in patients with chronic …

Questions about Pregnancy induced hypertension

Does planned early birth reduce maternal morbidity in late preterm hypertensive disorders of pregnancy?

Planned early birth for late preterm hypertensive disorders reduces maternal morbidity and stillbirth risk compared to waiting longer.

Full answer →
What factors predict retinopathy in patients with hypertensive disorders of pregnancy?

Early onset of disease, severe protein in urine, and low red blood cell levels predict retinopathy in hypertensive pregnancy disorders.

Full answer →

All Pregnancy induced hypertension Articles